Company news

IXICO PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

New contract worth >£1.0m

November 1, 2021

Contract update

October 20, 2021

Trading Update for year ended 30 September 2021

October 18, 2021

New contract worth >$750k

September 22, 2021

Phase II HD contract with new client worth >$500K

September 20, 2021

Phase I MSA contract award worth >$500k

September 8, 2021

Issue of Equity

June 23, 2021

Half yearly report to 31 March 2021

May 25, 2021

Phase II Alzheimer's disease contract award

May 20, 2021

Contract win for new neuroinflammatory disorder

May 19, 2021

Notice of results

May 11, 2021

Contract win for new stroke study

April 28, 2021

Trading update

April 26, 2021

PDMR Transaction

March 25, 2021

Huntington's disease Phase III contract updates

March 23, 2021

Collaboration with Microsoft

March 15, 2021

IXICO chosen for new Phase II AD study

March 10, 2021

IXICO selected by Cyclerion for a new AD study

March 2, 2021

Exercise of Options; PDMR Dealing

March 1, 2021

Conference attendance and presentations

March 1, 2021

PDMR Dealing

January 29, 2021

IXICO secures new contract for £3.4 million

December 24, 2020

IXICO contract with new large global pharma

December 8, 2020

Financial Results for the year ended 30 Sept 2020

December 2, 2020

IXICO announces £1.9 million new study award

November 27, 2020

Additional Alzheimer's disease contracts

November 3, 2020

Further Huntington's disease contracts

October 22, 2020

Trading Update for year ended 30 September 2020

October 19, 2020

IXICO to Present at SCA & ARCA Global Conference

October 19, 2020

IXICO and NYU Langone Health sign agreement

October 16, 2020

>£2m contract extension win - Huntington's disease

September 29, 2020

Collaboration with TRACK-FA NeuroimagingConsortium

September 24, 2020

IXICO selected to support Alzheimer's trial

September 21, 2020

Investor presentation

August 26, 2020

Conference attendance - On Helix Digital

July 8, 2020

Half yearly report to 31 March 2020

May 20, 2020

Trading update for H1 2020

April 20, 2020

£10.5m contract win, update on trading & COVID-19

April 14, 2020

IXICO announces expanded contract with Vaccinex

March 16, 2020

IXICO to Present AI Segmentation Research

February 19, 2020

IXICO to Present at Innovation Forum

February 10, 2020

IXICO Supports the AD Neuroimaging Initiative

February 3, 2020

IXICO announces updates to client contracts

December 23, 2019

Statement re Annual Report and Notice of AGM

December 20, 2019

PDMR share sale

December 9, 2019

Financial Results for the year ended 30 Sept 2019

December 4, 2019

IXICO to Present at Alzheimer's Disease Congress

December 2, 2019

IXICO to Present at HD and Ataxia Conferences

November 5, 2019

IXICO to Present at 10th Annual CNS Summit 2019

October 30, 2019

IXICO announces client contracts and appointed CBO

October 28, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.